Circonscription de l’EECA : la transition pourrait menacer des populations clés dans la région

Actualités

Circonscription de l’EECA : la transition pourrait menacer des populations clés dans la région

4 janvier 2017

La déclaration de l’EECA soutient que la situation épidémiologique alarmante actuelle, et une réduction de financement prévue, pourraient porter atteinte à la durabilité des résultats positifs dans le monde entier dans le domaine la lutte contre le SIDA, et mener à une mise en œuvre moins efficace du nouvel objectif mondial : éliminer le VIH en 2030. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

Joint statement of constituencies for the 36th Global Fund Board outlines problems and provides general recommendations

Along with the statement, the board received case studies on the EECA countries: Bulgaria, Bosnia and Herzegovina, Kosovo, Macedonia, Montenegro, Romania, Russia and Serbia. These country profiles provided overviews of the epidemiologic situation, schematic information about programs and service delivery, specific policy barriers and recommendations. Direct links between the statement and the case studies are not presented here however, the profiles attempted to emphasize the country-specific problems that are focused on in the general recommendations of the statement to the Fund.

Initially the statement covered two regions, EECA and EMR. While writing this article, we were informed that since submitting the statement to Office of Board Affairs, that both the LAC and SEA constituencies decided to ‘join’ the statement.

The epidemiological situation in the EECA is usually the main point of dispute between different advocacy campaigns that are trying to debate on decreasing donor contributions, though is unlikely to be taken into consideration as the countries with middle and high income are expected to contribute in controlling their own epidemics.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.